Literature DB >> 20338105

Endoscopic surgery for juvenile angiofibroma: a critical review of indications after 46 cases.

Piero Nicolai1, Andrea Bolzoni Villaret, Davide Farina, Sylvie Nadeau, Arkadi Yakirevitch, Marco Berlucchi, Cristina Galtelli.   

Abstract

BACKGROUND: At present, transnasal endoscopic surgery is considered a viable option in the management of small-intermediate size juvenile angiofibromas (JAs). The authors critically review their 14-year experience in the management of this lesion to refine selection criteria for an endoscopic approach.
METHODS: From January 1994 to May 2008, 46 patients were treated by a pure endoscopic resection after vascular embolization (87%). The lesions were classified according to Andrews (Andrews JC, et al., The surgical management of extensive nasopharyngeal angiofibromas with the infratemporal fossa approach, Laryngoscope 99:429-437, 1989) and Onerci (Onerci M, et al. Juvenile nasopharyngeal angiofibroma: A revised staging system, Rhinology 44:39-45, 2006) staging systems. All patients were followed by regular endoscopic and magnetic resonance imaging (MRI) examinations.
RESULTS: Lesions were classified as follows: stage I, n = 5; stage II, n = 24; stage IIIa, n = 14; stage IIIb, n = 3 according to Andrews classification system; stage 1, n = 9; stage II, n = 12; stage III, n = 26 according to Onerci's system. Unilateral blood supply was detected in 39 (85%) cases. Feeding vessels from the internal carotid artery (ICA) were also reported in 14 (30%) patients. Intraoperative blood loss ranged from 250 to 1300 mL (mean, 580 mL). In four (8.7%) cases, suspicious residual disease was detected by MRI. In one patient, a 1-cm persistent lesion was endoscopically removed because septoplasty was required and a slight increase in size was noticed. The other three lesions, all located in the root of the pterygoid plate, are nearly stable in size and are currently under MRI follow-up.
CONCLUSION: The improvement of surgical instrumentation and the experience acquired during a 14-year period have contributed to expanding the indications for endoscopic surgery in the management of JAs. Even stage III lesions may be successfully managed, unless the ICA is encased or if it provides an extensive blood supply. An external approach may be required when critical structures such as the ICA, cavernous sinus, or optic nerve are involved by lesions that are persistent after previous treatment; such a situation may prevent safe and radical dissection with a pure endoscopic approach. Better understanding of the factors influencing the growth of residual lesions is needed to differentiate those requiring re-treatment from those which can be simply observed.

Entities:  

Mesh:

Year:  2010        PMID: 20338105     DOI: 10.2500/ajra.2010.24.3443

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  12 in total

Review 1.  Comprehensive review on endonasal endoscopic sinus surgery.

Authors:  Rainer K Weber; Werner Hosemann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

Review 2.  Juvenile Angiofibroma: Current Management Strategies.

Authors:  Ahmad Safadi; Alberto Schreiber; Dan M Fliss; Piero Nicolai
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-18

3.  Comparison of surgical freedom and area of exposure in three endoscopic transmaxillary approaches to the anterolateral cranial base.

Authors:  Ali M Elhadi; Kaith K Almefty; George A C Mendes; M Yashar S Kalani; Peter Nakaji; Alexander Dru; Mark C Preul; Andrew S Little
Journal:  J Neurol Surg B Skull Base       Date:  2014-05-02

4.  Clinical Characteristics of Recurrent Juvenile Nasopharyngeal Angiofibroma (JNA) After Radiation Therapy.

Authors:  Ozan Gökdoğan; Beyhan Demirhan; Ahmet Koybasioglu; Fikret İleri
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-05-29

Review 5.  Inverted papillomas and benign nonneoplastic lesions of the nasal cavity.

Authors:  John W Wood; Roy R Casiano
Journal:  Am J Rhinol Allergy       Date:  2012 Mar-Apr       Impact factor: 2.467

6.  Contemporary Surgical Management of Juvenile Nasopharyngeal Angiofibroma.

Authors:  Salomon Cohen-Cohen; Kristen M Scheitler; Garret Choby; Jeffrey Janus; Eric J Moore; Jan L Kasperbauer; Harry J Cloft; Michael Link; Jamie J Van Gompel
Journal:  J Neurol Surg B Skull Base       Date:  2021-03-02

7.  Morbidity and Volumetric Progression in Juvenile Nasopharyngeal Angiofibroma in a Long-Term Follow-Up.

Authors:  Lorenz Epprecht; Marc Mosimann; Domenic Vital; David Holzmann
Journal:  J Neurol Surg B Skull Base       Date:  2018-04-09

8.  Association between vascular supply, stage and tumour size of juvenile nasopharyngeal angiofibroma.

Authors:  Raghav Mehan; V Rupa; Vijay Kumar Lukka; Munawar Ahmed; Vinu Moses; N K Shyam Kumar
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-11       Impact factor: 2.503

9.  Juvenile angiofibroma: evolution of management.

Authors:  Piero Nicolai; Alberto Schreiber; Andrea Bolzoni Villaret
Journal:  Int J Pediatr       Date:  2011-11-17

10.  Endoscopic endonasal approach for mass resection of the pterygopalatine fossa.

Authors:  Jan Plzák; Vít Kratochvil; Adam Kešner; Pavol Šurda; Aleš Vlasák; Eduard Zvěřina
Journal:  Clinics (Sao Paulo)       Date:  2017-10       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.